Loading insider details...
Latest Form 4 (Oct 16, 2026): Grant/Award of 23,394 ELVN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 16, 2026 | Enliven Therapeutics, Inc. (ELVN) | Grant/Award | 23,394 | n/a |
| Jun 3, 2026 | Oruka Therapeutics, Inc. (ORKA) | Grant/Award | 9,136 | n/a |
| Jun 3, 2025 | Oruka Therapeutics, Inc. (ORKA) | Grant/Award | 17,500 | n/a |